TNF-α-induced production of eosinophil chemotactic and activating factors by bronchial fibroblasts regulates the progression of asthmatic airway inflammation.
BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and ...
Autoimmune diseases stem from a complicated interplay of immune dysregulation, characterized by chronic inflammation and the loss of self-tolerance. Cytokines are central to these processes. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results